NUS provides new insights into neuronal behaviour

Biologics |  News | 0 Comment | 11 Apr, 2019

Dr Sajikumar Sreedharan and undergraduate student Karen Pang, PhD student Mahima Sharma, post-doctoral fellow Dr. Krishn...Read more

Researchers develop automated detection technique for eye surface cancer

Biologics |  News | 0 Comment | 03 Apr, 2019

A team of researchers from the Centre for Nanoscale BioPhotonics (CNBP) in Australia has developed a new automated non-i...Read more

FDA approves ASCENIV for the treatment of primary humoral immunodeficiency disease

Biologics |  News | 0 Comment | 02 Apr, 2019

ADMA Biologics, a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manu...Read more

GHIT selects joint research project on dengue by Chugai, A*STAR

Biologics |  News | 0 Comment | 02 Apr, 2019

Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, T...Read more

Scientists identify FLIP Inhibitors for cancer treatment

Biologics |  News | 0 Comment | 29 Mar, 2019

Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfull...Read more

Duke-NUS study reveals new treatment option for liver cancer

Biologics |  News | 0 Comment | 29 Mar, 2019

Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were...Read more

Duke-NUS study shows promise for heart muscle regeneration

Biologics |  News | 1 Comment | 25 Mar, 2019

Researchers at Duke-NUS Medical School, Singapore, have developed an approach to regenerate heart muscle using stem cell...Read more

NUS researchers develop self-healing electronic skin

Biologics |  News | 0 Comment | 22 Mar, 2019

Scientists from National University of Singapore (NUS) have taken inspiration from underwater invertebrates like jellyfi...Read more

Fujifilm to acquire Biogen in a $890 M deal

Biologics |  News | 0 Comment | 13 Mar, 2019

FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufactur...Read more

Ambrx, BeiGene to develop next-generation biologics

Biologics |  News | 0 Comment | 08 Mar, 2019

Ambrx Inc., a clinical-stage biopharmaceutical company focused on the development of innovative protein therapeutics and...Read more

Study: Inflammation in the brain enhances the side-effects of hypnotic medication

Biologics |  News | 0 Comment | 06 Mar, 2019

In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...Read more

Duke-NUS team reveals unknown mechanisms of zika infection

Biologics |  News | 0 Comment | 05 Mar, 2019

Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and ...Read more

Data sharing uncovers five new risk genes for Alzheimer’s disease

Biologics |  News | 0 Comment | 04 Mar, 2019

Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s diseas...Read more

Adagene to evaluate dynamic precision library platform with Celgene

Biologics |  Regulatory | 8 Comment | 04 Mar, 2019

China based Adagene, Inc., an innovative antibody discovery and engineering company, has announced a multi-target platfo...Read more

Link between GSL antigens and tumor survival in breast cancer found in a new research

Biologics |  News | 0 Comment | 19 Feb, 2019

A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI sci...Read more

Chipscreen Biosciences unites with Innovent for colorectal cancer therapy

Biologics |  News | 0 Comment | 18 Feb, 2019

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel s...Read more

Singapore researchers reveal role of anti-parasitic drug in treating cancer

Biologics |  News | 0 Comment | 15 Feb, 2019

Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-a...Read more

Researchers develop potential therapeutic model for Parkinson’s disease

Biologics |  News | 1 Comment | 12 Feb, 2019

Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...Read more